Journal ArticleOPEN ACCESS

Targeting CD38 in Refractory Extranodal Natural Killer Cell–T-Cell Lymphoma

  • Hari P
  • Raj R
  • Olteanu H
New England Journal of Medicine (2016) 375(15) 1501-1502
DOI: 10.1056/nejmc1605684
95Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Extranodal natural killer cell–T-cell lymphoma is a highly aggressive Epstein–Barr virus–related cancer. A woman with recurrent disease after many courses of therapy, including allogeneic hematopoietic-cell transplantation, had a complete response to anti-CD38 antibody.

Cite

CITATION STYLE

APA

Hari, P., Raj, R. V., & Olteanu, H. (2016). Targeting CD38 in Refractory Extranodal Natural Killer Cell–T-Cell Lymphoma. New England Journal of Medicine, 375(15), 1501–1502. https://doi.org/10.1056/nejmc1605684

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free